You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Federal mandates requiring frequent SARS-CoV-2 testing for nursing home employees and significant purchases of rapid antigen tests from HHS have raised concerns about capacity.
Some lab experts say that Abbott's test is open to multiple variables, which could lead to improper use and incorrect test results.
The letter cited the strain on non-COVID-19 care as laboratories struggle to meet demand for pre-procedure COVID-19 testing and other molecular tests.
The organizations requested a list of the names and contact information for individuals in each state overseeing the supply chain for testing supplies and PPE.
The insurer has issued new, lower, fee schedules to a number of Texas pathology labs, raising concerns that it could be part of a broader move to cut rates.
The PCR tests are being requested more often during the SARS-CoV-2 pandemic to rule out patients with other viral respiratory conditions.
News items for the in vitro diagnostics industry for the week of April 6, 2020.
In addition, Biolidics entered a distribution agreement with Clearbridge Medical Group to distribute tests in multiple Asian countries and Australia.
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
The registry is designed to help pathology practices comply with requirements under Medicare’s Quality Payment Program and Merit-Based Incentive Payment System.